AIM
DRNA

Acrospire Investment Management’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Acrospire Investment Management’s Portfolio DRNA Stock Details DRNA Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-6,064
Closed -$21K – 2669
2017
Q1 		$21K Sell
6,064
-3,843
-39% -$13.3K 0.02% 1613
2016
Q4 		$29K Buy
+9,907
New +$29K 0.01% 1646